期刊文献+

SENP蛋白在胶质瘤中表达与临床病理分级相关性 被引量:3

Expressions of SENP proteins in glioma and its correlation to clinical histological subclassification
原文传递
导出
摘要 目的探讨小泛素样修饰蛋白特异性蛋白酶(SENP)在人脑胶质瘤中的表达变化及与临床病理分级相关性。方法选择神经外科手术切除的脑胶质瘤组织43例作为胶质瘤组,尸解来源的正常脑组织9例作为对照组;Western blot法检测胶质瘤组与对照组中SENP1、SENP2、SENP6蛋白表达变化,并分析SENP蛋白表达量与患者临床病理分级之间关系。结果胶质瘤组织中SENP1、SENP2、SENP6蛋白表达量[分别为(0.47±0.12)、(0.78±0.17)、(0.94±0.21)]均明显增加,与对照组[分别为(0.35±0.03)、(0.36±0.13)、(0.23±0.08)]比较,差异有统计学意义(均P<0.05);脑胶质瘤组织中SENP1、SENP2、SENP6蛋白表达量与患者临床病理分级呈正相关(r=0.82、0.83、0.91,均P<0.05)。结论胶质瘤组织中SENP蛋白表达明显升高,SENP蛋白表达量与胶质瘤发生发展密切相关。 Objective To explore the change in expressions of small ubiquitin-related modifier-specific proteases (SENP) proteins in glioma and its correlation to clinical histological subclassification. Methods We selected 43 cases of glioma surgical resection as glioma group and 9 cases of normal brain tissue obtained from autopsy sources as control group. The change in expressions of SENP1, SENP2, and SENP6 proteins was detected with Western blot and the rela- tionship between the expression of SENP proteins and histological subclassification of glioma was analyzed. Results The expressions of SENP1 (0.47± 0. 12 ), SENP2 (0.78 ± 0. 17 ), and SENP6 (0.94±0.21 ) proteins were significantly increased in glioma tissues compared to those of the control group ( 0. 35 ± 0.03,0.36 ± 0. 13, and 0.23 ± 0.08 ), with statistically significant differences (all P 〈 0. 05 ) and the expression of SENP proteins was positively related to histological subclassification, with the correlation coefficients (r) of 0. 82,0. 83, and 0. 91 ( all P 〈 0. 05 ). Conclusion The ex- pression of SENP proteins increases in glioma tissues and closely relates to the development of glioma.
出处 《中国公共卫生》 CAS CSCD 北大核心 2015年第9期1219-1221,共3页 Chinese Journal of Public Health
基金 国家自然科学基金(81201671) 吉林省科技厅资助项目(20140414049GH) 吉林医药学院科研启动项目(201101)
关键词 小泛素样修饰蛋白(SUMO) SUMO特异性蛋白酶(SENP) 胶质瘤 病理分级 small ubiquitin-related modifier small ubiquitin-related modifier-specific proteases glioma pathological grade
  • 相关文献

参考文献15

二级参考文献80

共引文献32

同被引文献26

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1365
  • 2Qi L,Bellail AC,Rossi MR,et al.Heterogeneity of primary glioblastoma cells in the expression of caspase-8 and the response to TRAIL-induced apoptosis[J].Apoptosis,2011,16(11):1150-1164. 被引量:1
  • 3Bellail AC,Olson JJ,Hao C.SUMO1 modification stabilizes CDK6 protein and drives the cell cycle and glioblastoma progression[J].Nat Commun,2014,23(5):4234. 被引量:1
  • 4González-Santamaría J,Campagna M,Ortega-Molina A,et al.Regulation of the tumor suppressor PTEN by SUMO[J].Cell Death Dis,2012,27(3):e393. 被引量:1
  • 5Qin Y,Bao H,Pan Y,et al.SUMOylation alterations are associated with multidrug resistance in hepatocellular carcinoma[J].Mol Med Rep,2014,9(3):877-881. 被引量:1
  • 6Lee JS,Thorgeirsson SS.Genome-scale profiling of gene expression in hepatocellular carcinoma:classification,survival prediction,and identification of therapeutic targets[J].Gastroenterology,2004,127(5Suppl 1):S51-55. 被引量:1
  • 7Han JY,Lee GK,Yoo SY,et al.Association of SUMO1and UBC9 genotypes with tumor response in non-smallcelllung cancer treated with irinotecan-based chemotherapy[J].Pharmacogenomics J,2010,10(2):86-93. 被引量:1
  • 8Hsieh YL,Kuo HY,Chang CC,et al.Ubc9acetylation modulates distinct SUMO target modification and hypoxia response[J].EMBO J,2013,32(6):791-804. 被引量:1
  • 9Cao Q,Li YY,He WF,et al.Interplay between microRNAs and the STAT3 signaling pathway in human cancers[J].Physiol Genomics,2013,45(24):1206-1214. 被引量:1
  • 10Sozen S,Horozoglu C,Bireller ES,et al.Association of SUMO4 M55V and-94ins/del gene variants with type-2diabetes[J].In Vivo 2014,28(5):919-923. 被引量:1

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部